Skip to main content

Briacell Therapeutics Corp(BCT-T)
TSX

Today's Change
Real-Time Last Update
Volume

BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq

Globe Newswire - Wed Dec 29, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 29, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange ("TSX") as of the opening of trading on Friday, December 31, 2021 (the "Effective Date"). The Company's common shares will continue to trade under its existing Canadian market symbol "BCT". The Company's common shares will concurrently be de-listed from the TSX Venture Exchange ("TSX-V") as of the Effective Date. The common shares and publicly-traded warrants remain trading on the Nasdaq Capital Market ("Nasdaq") under the symbols BCTX and BCTXW, respectively.

Read more at globenewswire.com